Penelope Marr

499 total citations
11 papers, 307 citations indexed

About

Penelope Marr is a scholar working on Pathology and Forensic Medicine, Cell Biology and Molecular Biology. According to data from OpenAlex, Penelope Marr has authored 11 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Cell Biology and 4 papers in Molecular Biology. Recurrent topics in Penelope Marr's work include Skin and Cellular Biology Research (5 papers), Autoimmune Bullous Skin Diseases (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Penelope Marr is often cited by papers focused on Skin and Cellular Biology Research (5 papers), Autoimmune Bullous Skin Diseases (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Penelope Marr collaborates with scholars based in Australia, India and United Kingdom. Penelope Marr's co-authors include Dédée F. Murrell, Raymond A. Clarke, Eleni Yiasemides, Elaine Bolton, David L. Morris, Jonathan M. King, Maria Sarris, Peter E. Schwartz, Christopher J. Magarey and Judie Walton and has published in prestigious journals such as British Journal of Cancer, Histopathology and Journal of Dermatological Science.

In The Last Decade

Penelope Marr

11 papers receiving 298 citations

Peers

Penelope Marr
Matthew B. Smolkin United States
Suzi Safarians United States
Deepika Kassen United Kingdom
K Shiiba Japan
Penelope Marr
Citations per year, relative to Penelope Marr Penelope Marr (= 1×) peers Naomi De Luca

Countries citing papers authored by Penelope Marr

Since Specialization
Citations

This map shows the geographic impact of Penelope Marr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penelope Marr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penelope Marr more than expected).

Fields of papers citing papers by Penelope Marr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penelope Marr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penelope Marr. The network helps show where Penelope Marr may publish in the future.

Co-authorship network of co-authors of Penelope Marr

This figure shows the co-authorship network connecting the top 25 collaborators of Penelope Marr. A scholar is included among the top collaborators of Penelope Marr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penelope Marr. Penelope Marr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Yiasemides, Eleni, John Su, Ningning Dang, et al.. (2008). Clinical heterogeneity in recessive epidermolysis bullosa due to mutations in the keratin 14 gene, KRT14. Clinical and Experimental Dermatology. 33(6). 689–697. 22 indexed citations
3.
Dang, Ningning, Sandra Klingberg, Penelope Marr, & Dédée F. Murrell. (2007). Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants. Journal of Dermatological Science. 46(3). 169–178. 25 indexed citations
4.
Martin, Linda K., Adam I. Rubin, Kim Tran, et al.. (2006). A complicated blistering disease case demonstrating the usefulness of immunoblotting and ELISA for the diagnosis of immunobullous diseases. Australasian Journal of Dermatology. 47(4). 1 indexed citations
5.
Yiasemides, Eleni, et al.. (2006). A Comparative Study Between Transmission Electron Microscopy and Immunofluorescence Mapping in the Diagnosis of Epidermolysis Bullosa. American Journal of Dermatopathology. 28(5). 387–394. 43 indexed citations
6.
Yiasemides, Eleni, Judie Walton, Penelope Marr, Elmer Villanueva, & Dédée F. Murrell. (2006). A comparative study between electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa. Australasian Journal of Dermatology. 47(4). 2 indexed citations
7.
Haghighi, Koroush S., Winston Woon, Javed Akhter, et al.. (2004). A new source of hepatocytes for transplantation. Transplantation Proceedings. 36(8). 2466–2468. 8 indexed citations
8.
King, Jonathan M., Christopher J. Magarey, Peter E. Schwartz, et al.. (2000). Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?. British Journal of Cancer. 82(1). 167–170. 61 indexed citations
9.
Millar, Ewan K.A., et al.. (1999). Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology. 34(6). 491–496. 59 indexed citations
10.
Clarke, Raymond A., et al.. (1999). ATM protein synthesis patterns in sporadic breast cancer. Molecular Pathology. 52(5). 252–256. 32 indexed citations
11.
Marr, Penelope, et al.. (1998). NM23 GENE EXPRESSION IN GASTRIC CARCINOMA: AN IMMUNOHISTOCHEMICAL STUDY. Australian and New Zealand Journal of Surgery. 68(3). 180–182. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026